699 results match your criteria: "College of Radiology[Affiliation]"
Radiology
March 2021
From Mercy University Hospital, Grenville Place, Centre, Cork, T12 WE28, Ireland (A.P.B.); European Society of Radiology (ESR), Vienna, Austria (A.P.B., L.E.D., M.F.); Montefiore Medical Center, New York, NY (J. Bello); American College of Radiology (ACR), Reston, Va (J. Bello, J. Brink); University of Genoa, Genoa Italy (L.E.D.); Medical University Graz, Graz, Austria (M.F.); Monash University, Melbourne, Australia (S.G.); Royal Australian and New Zealand College of Radiologists (RANZCR), Sydney, Australia (S.G., J.S.); Erasmus Medical Center, Rotterdam, the Netherlands (G.P.K., J.J.V., J. Brink); International Society for Strategic Studies in Radiology (IS3R), Vienna, Austria (G.P.K., J.J.V.); Langley Memorial Hospital, Langley, Canada (E.J.Y.L.); Canadian Association of Radiologists (CAR), Ottawa, Canada (E.J.Y.L., J.P., R.E.A.W.); Thomas Jefferson University, Philadelphia, Pa (D.C.L., V.M.R.); Radiological Society of North America (RSNA), Oak Brook, Ill (D.C.L., V.M.R.); McGill University, Montreal, Canada (J.P.); Canadian Association of Radiologists (CAR), Ottawa, Canada (E.J.Y.L., J.P., R.E.A.W.); Flinders Medical Centre and Flinders University, Adelaide, Australia (J.S.); University of Calgary, Calgary, Canada (R.E.A.W.); Harvard Medical School, Boston, Mass (J. Brink).
Background The Value-Based Healthcare (VBH) concept is designed to improve individual healthcare outcomes without increasing expenditure, and is increasingly being used to determine resourcing of and reimbursement for medical services. Radiology is a major contributor to patient and societal healthcare at many levels. Despite this, some VBH models do not acknowledge radiology's central role; this may have future negative consequences for resource allocation.
View Article and Find Full Text PDFBackground: The Value-Based Healthcare (VBH) concept is designed to improve individual healthcare outcomes without increasing expenditure, and is increasingly being used to determine resourcing of and reimbursement for medical services. Radiology is a major contributor to patient and societal healthcare at many levels. Despite this, some VBH models do not acknowledge radiology's central role; this may have future negative consequences for resource allocation.
View Article and Find Full Text PDFJ Med Imaging Radiat Oncol
February 2021
American College of Radiology (ACR), Reston, Virginia, USA.
Background: The value-based healthcare (VBH) concept is designed to improve individual healthcare outcomes without increasing expenditure and is increasingly being used to determine resourcing of and reimbursement for medical services. Radiology is a major contributor to patient and societal healthcare at many levels. Despite this, some VBH models do not acknowledge radiology's central role; this may have future negative consequences for resource allocation.
View Article and Find Full Text PDFBackground: The Value-Based Healthcare (VBH) concept is designed to improve individual healthcare outcomes without increasing expenditure, and is increasingly being used to determine resourcing of and reimbursement for medical services. Radiology is a major contributor to patient and societal healthcare at many levels. Despite this, some VBH models do not acknowledge radiology's central role; this may have future negative consequences for resource allocation.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
April 2021
Providence St. Joseph Health, Eureka, California. Electronic address:
Purpose: Our purpose was to survey nationwide radiation oncology practices on their participation in, burden of, and satisfaction with the Medicare Access and Children's Health Insurance Program Reauthorization Act of 2015 (MACRA) payment programs.
Methods And Materials: All radiation oncology practices accredited by a national specialty organization were invited to participate in a voluntary online survey from December 2018 to January 2019. Questions focused on participation in the Merit-based Incentive Payment System (MIPS) in 2017 and 2018, as by the time of this survey, radiation oncology did not yet have a specialty-specific advanced Alternative Payment Model.
J Am Coll Radiol
May 2021
Vice Chair, Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania; Chief Medical Officer, The Radiology Leadership Institute, Reston, Virginia; Chair of the Commission on Leadership and Practice Development of the ACR, American College of Radiology, Reston, Virginia.
J Am Coll Radiol
April 2021
Professor and Vice Chair of Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, and Emory Healthcare, Atlanta, Georgia.
Purpose: To assess recent trends and characteristics in radiologist-practice separation across the United States.
Methods: Using the Medicare Physician Compare and Medicare Physician and Other Supplier Public Use File data sets, we linked all radiologists to associated group practices annually between 2014 and 2018 and assessed radiologist-practice separation over a variety of physician and group characteristics. Multivariate logistic regression modeling was used to estimate the likelihood of radiologist-practice separation.
Radiology
January 2021
From the American College of Radiology, Reston, Va (J.C.W., C.L.W., R.J.M., J.R.D., M.S.D.); National Kidney Foundation, New York, NY (R.A.R., J.Y., D.F., M.A.P.); Department of Radiology and Biomedical Imaging (J.C.W.) and Department of Internal Medicine, Section of Nephrology (M.A.P.), Yale University School of Medicine, New Haven, Conn; Department of Nephrology, Rush University Medical Center, Chicago, Ill (R.A.R.); Department of Nephrology, Henry Ford Health System, Detroit, Mich (J.Y.); Department of Radiology, University of Washington, Seattle, Wash (C.L.W.); Department of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Md (D.F.); Department of Radiology, Mayo Clinic, Rochester, Minn (R.J.M.); Department of Radiology, Cincinnati Children's Hospital Medical Center at University of Cincinnati College of Medicine, Cincinnati, Ohio (J.R.D.); Departments of Radiology (M.S.D.) and Urology (M.S.D.), Michigan Medicine, 1500 E Medical Center Dr, Room B2 A209P, Ann Arbor, MI 48109-5030; and Michigan Radiology Quality Collaborative, Ann Arbor, Mich (M.S.D.).
Inaugural consensus statements were developed and endorsed by the American College of Radiology (ACR) and the National Kidney Foundation to improve and standardize the care of patients with kidney disease who have indication(s) to receive ACR-designated group II or group III intravenous gadolinium-based contrast media (GBCM). The risk of nephrogenic systemic fibrosis (NSF) from group II GBCM in patients with advanced kidney disease is thought to be very low (zero events following 4931 administrations to patients with estimated glomerular filtration rate [eGFR] <30 mL/min per 1.73 m; upper bounds of the 95% confidence intervals: 0.
View Article and Find Full Text PDFJ Am Coll Radiol
March 2021
Vice Chair of Education and Clinical Operations, Department of Radiology, Stanford University School of Medicine, Stanford, California.
Purpose: To determine the effect of coronavirus disease 2019 (COVID-19) on CT volumes in the United States during and after the first wave of the pandemic.
Methods: CT volumes from 2,398 US radiology practices participating in the ACR Dose Index Registry from January 1, 2020, to September 30, 2020, were analyzed. Data were compared to projected CT volumes using 2019 normative data and analyzed with respect to time since government orders, population-normalized positive COVID-19 tests, and attributed deaths.
J Am Coll Radiol
January 2021
Assistant Professor, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia; Assistant Professor, Emory University Rollins School of Public Health, Atlanta, Georgia.
Objective: The primary objectives of this investigation were to evaluate the use of screening CT colonography (CTC) examinations by age comparing individuals of Medicare-eligible age to younger cohorts and to determine if the association between use of CTC and Medicare-eligible age varies by race. Although the Affordable Care Act requires commercial insurance coverage of screening CTC, Medicare does not cover screening CTC.
Materials And Methods: Using the ACR's CTC registry, the distribution of procedures by age was evaluated using a negative binomial model with patient age (to capture overall trend), indicator of Medicare-eligible age (to capture immediate changes in trend at age 65), and their interaction (to capture gradual changes after age 65) as independent variables.
Cancer
December 2020
Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Background: This study was designed to test the hypothesis that the effectiveness of intensive treatment for locoregionally advanced head and neck cancer (LAHNC) depends on the proportion of patients' overall event risk attributable to cancer.
Methods: This study analyzed 22,339 patients with LAHNC treated in 81 randomized trials testing altered fractionation (AFX; Meta-Analysis of Radiotherapy in Squamous Cell Carcinomas of Head and Neck [MARCH] data set) or chemotherapy (Meta-Analysis of Chemotherapy in Head and Neck Cancer [MACH-NC] data set). Generalized competing event regression was applied to the control arms in MARCH, and patients were stratified by tertile according to the ω score, which quantified the relative hazard for cancer versus competing events.
Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced kidney function following exposure to intravenous iodinated contrast media has been overstated. This is due primarily to historic lack of control groups sufficient to separate contrast-induced AKI (CI-AKI; ie, AKI caused by contrast media administration) from contrast-associated AKI (CA-AKI; ie, AKI coincident to contrast media administration).
View Article and Find Full Text PDFJ Am Coll Radiol
January 2021
Society of Radiologists in Ultrasound Executive Board, Reston, Virginia; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Current descriptions of ultrasound evaluations, including use of the term "point-of-care ultrasound" (POCUS), are imprecise because they are predicated on distinctions based on the device used to obtain images, the location where the images were obtained, the provider who obtained the images, or the focus of the examination. This is confusing because it does not account for more meaningful distinctions based on the setting, comprehensiveness, and completeness of the evaluation. In this article, the Society of Radiologists in Ultrasound and the members of the American College of Radiology Ultrasound Commission articulate a map of the ultrasound landscape that divides sonographic evaluations into four distinct categories on the basis of setting, comprehensiveness, and completeness.
View Article and Find Full Text PDFAbdom Radiol (NY)
December 2020
American College of Radiology, Reston, VA, USA.
The use of prostate MRI for prostate cancer evaluation continues to rise and ensuring minimum quality standards across practices will enable optimal diagnostic accuracy and thus, patient care. The American College of Radiology has been working on quality standards to meet Prostate MRI Designated Center, which is expected to launch in late 2020. We discuss the background of the American College of Radiology Prostate MRI working group's effort and summarize the criteria for Prostate MRI Designation.
View Article and Find Full Text PDFPurpose: NRG Oncology, part of the National Cancer Institute's National Clinical Trials Network, took efforts to increase patient-reported outcome measures (PROMs) completion and institutional data submission rates within clinical trials. Lack of completion diminishes power to draw conclusions and can be a waste of resources. It is hypothesized that trials with automatic email reminders and past due notifications will have PROM forms submitted more timely with higher patient completion.
View Article and Find Full Text PDFLancet Haematol
September 2020
Division of Hematology, Mayo Clinic, Rochester MN, USA.
Background: Recognising that the immune suppressive microenvironment promotes tumour growth in Hodgkin lymphoma, we hypothesised that activating immunity might augment the activity of targeted chemotherapy. We evaluated the safety and activity of combinations of brentuximab vedotin with nivolumab or ipilimumab, or both in patients with relapsed or refractory Hodgkin lymphoma.
Methods: In this multicentre, open-label, phase 1/2 trial, patients with relapsed or refractory Hodgkin lymphoma aged 18 years or older who had relapsed after at least one line of therapy, with an Eastern Cooperative Oncology Group performance status of 2 or lower, and adequate organ and marrow function, with no pulmonary dysfunction were eligible for inclusion.
J Am Coll Radiol
November 2020
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Feinstein Institutes for Medical Research, Manhasset, New York.
Purpose: The coronavirus disease 2019 (COVID-19) pandemic affected radiology practices in many ways. The aim of this survey was to estimate declines in imaging volumes and financial impact across different practice settings during April 2020.
Methods: The survey, comprising 48 questions, was conducted among members of the ACR and the Radiology Business Management Association during May 2020.
J Am Coll Radiol
November 2020
Vice Chair, Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania and UPMC International; Chief Medical Officer, The Radiology Leadership Institute; and Chair of the Commission on Leadership and Practice Development of the ACR, American College of Radiology, Reston, Virginia.
J Am Coll Radiol
November 2020
Chair, Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Since its introduction nearly 20 years ago, score-based peer review has not been shown to have meaningful impact on or be a valid measurement instrument of radiologist performance. A new paradigm has emerged, peer learning, which is a group activity in which expert professionals review one another's work, actively give and receive feedback in a constructive manner, teach and learn from one another, and mutually commit to improving performance as individuals, as a group, and as a system. Many radiology practices are beginning to transition from score-based peer review to peer learning.
View Article and Find Full Text PDFAJR Am J Roentgenol
February 2021
Department of Radiology, UC Davis School of Medicine, Sacramento, CA.
The purpose of this study was to investigate whether systematic bias in attenuation measurements occurs among CT scanners made by four major manufacturers and the relevance of this bias regarding opportunistic screening for osteoporosis. Data on attenuation measurement accuracy were acquired using the American College of Radiology (ACR) accreditation phantom and were evaluated in a blinded fashion for four CT manufacturers (8500 accreditation submissions for manufacturer A; 18,575 for manufacturer B; 8278 for manufacturer C; and 32,039 for manufacturer D). The attenuation value for water, acrylic (surrogate for trabecular bone), and Teflon (surrogate for cortical bone; Chemours) materials for an adult abdominal CT technique (120 kV, 240 mA, standard reconstruction algorithm) was used in the analysis.
View Article and Find Full Text PDFFront Psychiatry
June 2020
Department of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Background: The amygdala has been proposed to be involved in the pathophysiology of pediatric and adult bipolar disorder (BD). The goal of this structural magnetic resonance imaging (sMRI) study was to investigate the morphometric characteristics of amygdala subnuclei in patients with pediatric bipolar disorder (PBD) compared to healthy controls (HCs). Simultaneously, we examined correlation between amygdala subnuclei volumes and cognitive dysfunction.
View Article and Find Full Text PDFJ Am Coll Radiol
December 2020
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Scientific Director (CCDS), Director (QTIM lab and the Center for Machine Learning), Associate Professor of Radiology, MGH/Harvard Medical School, Boston, Massachusetts. Electronic address:
Objective: We developed deep learning algorithms to automatically assess BI-RADS breast density.
Methods: Using a large multi-institution patient cohort of 108,230 digital screening mammograms from the Digital Mammographic Imaging Screening Trial, we investigated the effect of data, model, and training parameters on overall model performance and provided crowdsourcing evaluation from the attendees of the ACR 2019 Annual Meeting.
Results: Our best-performing algorithm achieved good agreement with radiologists who were qualified interpreters of mammograms, with a four-class κ of 0.
Int J Radiat Oncol Biol Phys
November 2020
Emory University Hospital, Winship Cancer Institute, Atlanta, Georgia.
Purpose: To assess the reasons why patients do not consent to patient-reported outcome (PRO) and electronic PRO data capture components of clinical trials and potential selection bias by having a separate consent.
Methods And Materials: Selected NRG Oncology trials were included based on disease site and inclusion of PROs and electronic PRO data capture via VisionTree Optimal Care as separate consent questions. Reasons for not participating were assessed.
J Clin Oncol
August 2020
Royal Marsden Hospital, London, United Kingdom.
Purpose: To compare cisplatin plus fluorouracil (FU) versus carboplatin plus paclitaxel in chemotherapy-naïve advanced anal cancer to establish the optimal regimen.
Patients And Methods: Patients who had not received systemic therapy for advanced anal cancer were randomly assigned 1:1 to intravenous cisplatin 60 mg/m (day 1) plus FU 1,000 mg/m (days 1-4) every 21 days or carboplatin (area under the curve, 5; day 1) plus paclitaxel 80 mg/m (days 1, 8, and 15) every 28 days for 24 weeks, until disease progression, intolerable toxicity, or withdrawal of consent. Primary end point was objective response rate (ORR).